Tenaya raises about $53M; BeiGene’s PD-1 gets a first-line approval

Plus, news about Evotec and Osivax: Tenaya Therapeutics’ $52.5M public offering: The heart disease specialist intends to spend the proceeds from its offering of 75 million new shares to develop treatments ...